Active
    SME

    Avience Biomedicals Ltd

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Avience Biomedicals Ltd IPO opened on 18 Jun 2026 and closed on 22 Jun 2026, with a price band of ₹196–₹208 per share. The IPO had a lot size of 600 shares, requiring a minimum investment of ₹2,49,600 per lot at the upper price band. The issue size was ₹30.24 crore, and the shares get listed on 25 Jun 2026.

    Avience Biomedicals Ltd IPO Details

    Listing Date

    25 Jun 2026

    Bid Price

    ₹196 - ₹208

    Lot Size

    600 Shares

    Minimum Investment

    ₹2,49,600 / 2 Lots

    Issue Size

    ₹30.24 Cr

    Key Dates to Track

        Here are the important dates you need to know in order to participate in this IPO

    tick

    Offer Start Date

    18th Jun

    tick

    Offer End Date

    22nd Jun

    tick

    Allotment Date

    23rd Jun

    tick

    Refund Initiation

    24th Jun

    tick

    Demat Transfer

    24th Jun

    tick

    Listing Date

    25th Jun

    About Avience Biomedicals Ltd IPO

    Avience Biomedicals Limited is an ISO-certified company engaged in the manufacturing, supply, export, distribution, and trading of diagnostic and medical equipment solutions. The company serves the biotechnology, genomics, and in-vitro diagnostics (IVD) segments, offering products to pathology laboratories, microbiology laboratories, hospitals, and research institutions in India and overseas. Its manufacturing facility is located in Noida, Uttar Pradesh. The company began its operations with diagnostic products such as Viral Transport Media (VTM) and various rapid test kits used across healthcare settings. Over time, it has broadened its product portfolio to address a wider range of diagnostic requirements.
     

    The company's offerings include rapid test kits, molecular diagnostic solutions, biochemistry analysers, reagents, haematology analysers, and selected medical devices such as oxygen concentrators. Avience Biomedicals primarily caters to business-to-business (B2B) and business-to-government (B2G) customers. Originally incorporated as Avience Biomedicals Private Limited in December 2019, the company was subsequently converted into a public limited company in September 2024 and renamed Avience Biomedicals Limited. As of January 31, 2026, the company had a workforce comprising 75 permanent employees and 33 contractual employees supporting its operations across various functions.

    Avience Biomedicals Ltd Shareholding Pattern

      Pre-Issue Post-Issue
    Promoter Group 87.89% 64.59%
    Public Group 12.11% 35.41%

    Avience Biomedicals Ltd IPO Reservation

    QIB Shares Offered 2,73,600 (18.82%)
    NII (HNI) Shares Offered 2,07,000 (14.24%)
    Retail Shares Offered 4,81,200 (33.1%)
    Anchor Investor Shares Offered 4,09,800 (28.19%)
    Total Shares Offered 14,53,800
    Total Shares With Anchor Investor 14,53,800

    Avience Biomedicals Ltd IPO Lot Size

    Application Lots Shares Amount
    Retail (Min) 2 1,200 ₹2,49,600
    Retail (Max) 2 1,200 ₹2,49,600
    S HNI (Min) 3 1,800 ₹3,74,400
    S HNI (Max) 8 4,800 ₹9,98,400
    B HNI (MIN) 9 5,400 ₹11,23,200

    Avience Biomedicals Ltd IPO Anchor Portion Size

    Bid Date June 17, 2026
    Shares Offered 4,09,800
    Anchor Investment Details 8

    Avience Biomedicals Ltd IPO registrar

    Skyline Financial Services Pvt
    Phone Number 011-40450193-197
    Email Id ipo@skylinerta.com
    Website www.skylinerta.com

    Avience Biomedicals Ltd IPO Lead Manager

    1. Fintellectual Corporate Advisors Pvt Ltd

    Avience Biomedicals Ltd Financial Information

    March 31, 2026 March 31, 2025 March 31, 2024
    Net Worth ₹31.41 Cr ₹22.66 Cr ₹6.23 Cr
    Reserves and Surplus ₹27.38 Cr ₹18.63 Cr ₹2.94 Cr
    Total Borrowing ₹28.93 Cr ₹22.16 Cr ₹15.13 Cr

    Avience Biomedicals Ltd IPO Subscription LIVE Status

    Category No. of shares offered No. of shares bid Subscription (Times)
    Qualified Institutional Buyers (QIBs) 2,73,600 5,38,37,400 196.7741
    Non Institutional Investors (NIIs) 2,89,200 12,37,09,800 427.7656
    Retail Individual Investors (RIIs) 4,81,200 19,31,32,800 401.3566
    Total 10,44,000 37,06,80,000 355.0575

    Strength of Avience Biomedicals Ltd

    • Experienced Management Team and trained Employees.
    • Optimal Utilization of Resources.
    • Quality assurance and control.
    • Cordial relationships with our clients.

    Risks Involved

    • The pharmaceutical market is subject to extensive regulation and failures to comply with the existing and future regulatory requirements in any pharmaceutical market could expose its to litigation or other liabilities, which could adversely affect the company reputation, business, financial condition and results of operations.
    • The company is dependent on certain customers for a portion of its revenues. The loss of any of its major customers dues to any adverse development or significant reduction in business from its major customers may adversely affect the company business, financial condition, results of operations and future prospects.
    • The company relies on suppliers for medical devices and equipment manufacturers for its trading goods, and also faces risks in sourcing raw materials and components from third parties for the manufacturing and assembly of its medical equipment. Any disruption in the supply of these goods or materials could adversely impact the company business, operations, and financial condition.
    • The company Financial Statement as Restated are prepared and signed by the Peer Review Auditor who is not Statutory Auditors of its Company as required under the provisions of ICDR.
    • The company business derives a significant portion of its revenue from the trading sector, and any potential instability in this area could pose a risk to the company overall performance.
    • The purchase and sale of medical devices and equipment for the company trading activities is significantly dependent on related parties.
    • Customer orders may experience delays, modifications, cancellations, or may not be fully paid, which could negatively impact the company business, financial condition, and operational results.
    • The company requires sizeable amounts of working capital for its continued operation and growth. The company inability to meet its working capital requirements could has a material adverse effect on the company business, results of operations and financial condition.
    • The company business depends on the efficient functioning of its manufacturing facilities and assembly units. Although the company has not received any product-related complaints, occasional machinery breakdowns in the past highlight the importance of regular maintenance and operational enhancements. Any unforeseen obsolescence, damage, theft, or delays in repair could has an adverse impact on the company operations, cash flows, financial condition, and results.
    • The company import a portion of its raw material supply from China. Restrictions on or import duties relating to materials and equipment imported for the company manufacturing operations as well as restrictions on or import duties levied on its products in the company export markets may adversely affect its business prospects, financial performance and cash flows.

    Invest in IPOs with ease

    Sign-in to invest with your demat account, or set up a new demat account for free

    Industry Outlook of Avience Biomedicals IPO

    • The Indian pharmaceuticals industry is an important participant in the global pharmaceuticals market, with key segments including diagnostic kits, medical devices, and related healthcare products.

    • India's healthcare and medical device sectors have recorded notable expansion over the past decade.

    • The country manufactures a broad range of medical devices, covering consumables, diagnostic equipment, and implantable devices used across various healthcare settings.

    • Commonly manufactured products include biochemistry analysers, diagnostic reagents, and devices used in haematology and immunology applications.

    • The medical devices industry is capital-intensive, requiring substantial investment in manufacturing infrastructure, research, and technology development.

    • Continuous training and skill development are necessary for healthcare professionals to effectively utilise evolving medical technologies and equipment.

    • The Indian laboratory diagnostics industry is estimated at approximately USD 18.5 billion and has been expanding at an annual rate of around 13–14%.

    • More than 100,000 laboratories operate across India, collectively offering a broad portfolio of diagnostic tests, with some facilities providing up to 4,500 different tests.

    • The industry is known for offering diagnostic services at comparatively low price points.

    Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Avience Biomedicals IPO.

    Explore Other IPOs

    • Current IPOs
    • Upcoming IPOs
    • Closed IPOs
    • IPO Performance
    • All
    • MainBoard
    • SME
    CORE4 ENGINEERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    23rd Oct 2026 - 10th Oct 2026
    Price Range
    ₹88.0 - 93.0
    IPO Size
    ₹54,82,00,000
    • All
    • MainBoard
    • SME
    Bidding Period
    26th Oct 2026 - 10th Oct 2026
    Price Range
    ₹1585.0 - 1665.0
    IPO Size
    ₹12,00,00,00,000
    BLS Polymers Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹142.0 - 150.0
    IPO Size
    ₹2,55,00,00,128
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹313.0 - 330.0
    IPO Size
    ₹6,67,53,00,352
    Wiscon Industries Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹194.0 - 204.0
    IPO Size
    ₹1,10,00,00,000
    Carver Roboweld Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Oct 2026 - 10th Oct 2026
    Price Range
    ₹76.0 - 80.0
    IPO Size
    ₹28,29,00,000
    M K Sons Fine Jewels Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹153.0 - 162.0
    IPO Size
    ₹2,75,39,99,872
    Bidding Period
    29th Oct 2026 - 11th Nov 2026
    Price Range
    ₹78.0 - 82.0
    IPO Size
    ₹1,83,05,99,936
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanced SysTek Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanta Enterprises Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Agilus Diagnostics Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AGS Health Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Airox Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AITMC Ventures Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ajay Poly Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Allchem Lifescience Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    NO ACTIVE IPO HERE
    • All
    • MainBoard
    • SME
    JIO PLATFORMS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹1065.0 - 1119.0
    IPO Size
    ₹3,02,13,00,03,968
    PARAS HEALTHCARE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹660.0 - 693.0
    IPO Size
    ₹14,49,99,99,744
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹327.0 - 344.0
    IPO Size
    ₹4,75,48,00,128
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹558.0 - 586.0
    IPO Size
    ₹25,33,80,99,712
    SHELLZ INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹170.0 - 179.0
    IPO Size
    ₹59,97,00,032
    TONBO IMAGING INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹665.0 - 700.0
    IPO Size
    ₹8,52,17,99,680
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹143.0 - 151.0
    IPO Size
    ₹50,12,33,00,864
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹275.0 - 289.0
    IPO Size
    ₹7,02,00,00,256
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹105.0 - 112.0
    IPO Size
    ₹1,16,04,99,968
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹258.0 - 271.0
    IPO Size
    ₹7,12,12,99,968
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹51.0 - 54.0
    IPO Size
    ₹42,10,00,000
    Bidding Period
    5th Oct 2026 - 10th Oct 2026
    Price Range
    ₹77.0 - 82.0
    IPO Size
    ₹34,99,00,032
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹119.0 - 127.0
    IPO Size
    ₹81,79,00,032
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹186.0 - 196.0
    IPO Size
    ₹1,21,68,99,968
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹37,86,00,000
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Sep 2026 - 10th Oct 2026
    Price Range
    ₹50.0 - 53.0
    IPO Size
    ₹31,80,00,000
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹67.0 - 67.0
    IPO Size
    ₹23,45,00,000
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹55.0 - 55.0
    IPO Size
    ₹21,78,00,000
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹208.0 - 220.0
    IPO Size
    ₹1,78,00,00,000
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹112.0 - 118.0
    IPO Size
    ₹38,12,00,000
    • All
    • MainBoard
    • SME
    Issue Prize
    1785.00
    Listing Day Close
    1818.00(1.85%)
    LAPL AUTOMOTIVE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    94.00
    Listing Day Close
    128.29(36.17%)
    Issue Prize
    344.00
    Listing Day Close
    378.20(9.88%)
    Issue Prize
    586.00
    Listing Day Close
    576.35(-1.71%)
    SHELLZ INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    179.00
    Listing Day Close
    170.05(-5.03%)
    TONBO IMAGING INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    700.00
    Listing Day Close
    1133.65(62.00%)
    Issue Prize
    151.00
    Listing Day Close
    138.30(-8.61%)
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    289.00
    Listing Day Close
    289.75(0.35%)
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    271.00
    Listing Day Close
    307.20(13.28%)
    Issue Prize
    112.00
    Listing Day Close
    113.70(1.79%)
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    54.00
    Listing Day Close
    53.05(-1.85%)
    Issue Prize
    82.00
    Listing Day Close
    76.00(-7.32%)
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    127.00
    Listing Day Close
    109.25(-14.17%)
    Issue Prize
    196.00
    Listing Day Close
    232.05(18.37%)
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    70.00
    Listing Day Close
    58.80(-15.71%)
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    53.00
    Listing Day Close
    57.00(7.55%)
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    67.00
    Listing Day Close
    73.01(8.96%)
    Issue Prize
    55.00
    Listing Day Close
    99.18(80.00%)
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    220.00
    Listing Day Close
    204.25(-7.27%)
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    118.00
    Listing Day Close
    105.45(-11.02%)

    Frequently Asked Questions

    What is Avience Biomedicals Ltd IPO?

    Avience Biomedicals Ltd IPO is a SME IPO of 14,53,800 equity shares of a face value of ₹10 aggregating up to ₹30.24 Crores. The issue is priced at ₹196 to ₹208 per share. The minimum order quantity is 600 Shares. The IPO opens on June 18, 2026, and closes on June 22, 2026. Skyline Financial Services Pvt is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

    When Avience Biomedicals Ltd IPO will open?

    The Avience Biomedicals Ltd IPO opens on June 18, 2026 and closes on June 22, 2026.

    What is the lot size of Avience Biomedicals Ltd?

    Avience Biomedicals Ltd lot size is 600 shares, and the minimum amount required is ₹2,49,600.

    How to apply for Avience Biomedicals Ltd IPO?

    You can apply in Avience Biomedicals Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

    • Login to Bajaj Broking account App/Website & click on IPO
    • Enter the number of lots and price at which you wish to apply.
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
    • You will receive a mandate notification to block funds in your UPI app.
    • Approve the mandate request on your UPI and funds will be blocked.

    When is Avience Biomedicals Ltd IPO allotment?

    The finalization of Basis of Allotment for Avience Biomedicals Ltd IPO will be done on June 23, 2026, and the allotted shares will be credited to your demat account by June 24, 2026.

    When is Avience Biomedicals Ltd IPO listing date?

    The Avience Biomedicals Ltd listing date is June 25, 2026.

    Who is the registrar of Avience Biomedicals Ltd IPO?

    The registrar of Avience Biomedicals Ltd IPO is Skyline Financial Services Pvt

    Which company is the book-running lead manager of the IPO?

    Fintellectual Corporate Advisors Pvt Ltd will be the book-running lead manager of this IPO.

    What is the fresh issue of Avience Biomedicals Ltd IPO?

    The fresh issue size is ₹30.24 Crores equity shares.

    What minimum lot size can retail subscribers subscribe to Avience Biomedicals Ltd?

    Retail investors can subscribe to a minimum of one lot, 600 shares and ₹2,49,600 amount.

    How can I approve the UPI mandate request for Avience Biomedicals Ltd IPO?

    To apply for Avience Biomedicals Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

    What is the price range of Avience Biomedicals Ltd?

    The price of each Avience Biomedicals Ltd share will be ranging in between ₹196 to ₹208 per share.

    What is the cut-off time for the UPI mandate for Avience Biomedicals Ltd IPO?

    The cut-off time for the UPI mandate confirmation is 5:00 PM, June 22, 2026.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |